European researchers have shown that NOD2 deficiency can disrupt enteric microbiota and predispose the host to colitis and colitis-associated cancer. The group is seeking to understand how NOD2 deficiency leads to microbiota disruption and is looking for bacterial strains that could correct the microbial imbalance.